Thrombus formation within hepatic vein after Fontan procedure  by Watanabe, Manabu et al.
Brief
CommunicationsThrombus formation within hepatic vein after Fontan procedure
Manabu Watanabe, MD, Mitsuru Aoki, MD, PhD, Nobuyuki Ishibashi, MD, and Tadashi Fujiwara, MD, PhD, Chiba City,
JapanFrom the Unit of Cardiovascular Surgery,
Chiba Children’s Hospital, Chiba City,
Japan.
Received for publication Sept 20, 2006;
accepted for publication Sept 25, 2006.
Address for reprints: Manabu Watanabe,
MD, Unit of Cardiovascular Surgery, Hok-
kaido Children’s Medical Center, 1-10-1,
Zenibako, Otaru, Hokkaido, Japan (E-mail:
dookuman@beige.ocn.ne.jp).
J Thorac Cardiovasc Surg 2008;136:519-20
0022-5223/$34.00
Copyright  2008 by The American Asso-
ciation for Thoracic Surgery
doi:10.1016/j.jtcvs.2006.09.129T
hrombus formation is an important complication after Fontan procedure.1 Although
thrombus formation is commonly seen either in the systemic venous pathway or in
the pulmonary venous pathway, to the best of our knowledge there have been no re-
ports of thrombus formation within the hepatic vein. Here we present two cases of
unusual intrahepatic thrombus formation after the Fontan procedure.
Clinical Summaries
PATIENT 1. A 4-year-old girl was being followed up at our hospital for the diagnosis of pulmo-
nary atresia with intact ventricular septum. She had undergone a bidirectional cavopulmonary
shunt at the age of 3 years. In September 2004, she underwent a Fontan procedure. The proce-
dure consisted of anastomosis between the proximal stump of the superior vena cava (SVC) and
the pulmonary artery and creation of lateral tunnel from the inferior vena cava (IVC) to the or-
ifice of the SVC. A tunnel of sufficient caliber was created with in situ atrial free wall. Postop-
erative echocardiography showed good cardiac function and unobstructed cavopulmonary
pathway. For anticoagulation, drip infusion of heparin and oral intake of aspirin were started
on postoperative day (POD) 1. On POD 3, blood data showed elevation of hepatic enzymes (as-
partate aminotransferase 1010 IU/L, alanine aminotransferase 940 IU/L). Abdominal echogra-
phy showed dilated hepatic veins and a thrombus 10 mm in diameter at the confluence of right,
middle, and left hepatic veins (Figure 1). Therapy with warfarin was started to prevent further
enlargement of the thrombus. The values of the hepatic enzymes dropped gradually and were
within reference range on POD 14.
PATIENT 2. A 2-year-old boy had the same diagnosis as patient 1. He had undergone bidirec-
tional cavopulmonary shunt at the age of 1 year. Creation of the lateral tunnel from the IVC to
the orifice of the SVC was performed as in patient 1, and the postoperative course was unevent-
ful. Thrombus at the confluence of hepatic vein and IVC was found by abdominal echography
performed on POD 14. The thrombus extended into the middle hepatic vein, and part of it
protruded into the IVC (Figure 1). There was neither elevation of hepatic enzymes nor hepatic
venous dilation, and therapy with warfarin was started.
In both cases, preoperative measurements of hematologic parameters, serum protein, renal
and liver function parameters, and coagulation status were within reference ranges. Cardiopul-
monary bypass was instituted with ascending aortic perfusion, and bicaval venous drainage was
performed with L-shaped venous cannulas inserted directly into the SVC and IVC.
In both cases, thrombi had disappeared within 2 weeks after the initiation of warfarin therapy
(Figure 1), and lung perfusion scintigraphy showed no sign of pulmonary embolism. Both
patients have been followed up for 2 years and show no signs of thrombus.
Discussion
We report 2 rare cases of intrahepatic thrombus formation after the Fontan operation. Several
predisposing risk factors for the development of thrombi have been proposed. Slow and non-
pulsatile flow through the caval veins and low cardiac output are inherent in the physiology
of all patients after the Fontan operation, regardless of the type of cavopulmonary connection.
In addition, some reports suggest that an imbalance in coagulation proteins after the Fontan
operation may predispose toward the development of thrombus.2,3 In our 2 cases, there were
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Brief CommunicationsFigure 1. Upper panels show thrombi formed
within hepatic veins in patients 1 (left) and 2
(right). As shown in lower panels, thrombi in
both patients 1 (left) and 2 (right) had disappeared
within 2 weeks. RHV, Right hepatic vein; MHV,
middle hepatic vein; LHV, left hepatic vein; TH,
thrombus; IVC, inferior vena cava.neither obstruction of cavopulmonary pathway nor significant ab-
normalities in coagulation proteins. Relative to other cases, there
was no significantly increased physiologic risk factor that would
precipitate the formation of thrombus.
The other explanation for the formation of the intrahepatic
thrombi is possible hepatic venous endothelial injury at the time
of cannulation to the IVC. In general, a distance between the Eusta-
chian valve and the upper margin of the opening of the hepatic vein
is short, and the tip of the venous cannula may be inserted inciden-
tally. In a study with transesophageal echocardiography, the inci-
dence of the venous cannula being primarily placed in the hepatic
vein was nearly 10%.4 Both the endothelial injury and the slow
flow velocity within cavopulmonary tract thus may have contributed
to the formation of the hepatic venous thrombi in these 2 cases.
It has been our institutional approach to avoid routine anticoagu-
lation therapy with warfarin after a Fontan operation unless the520 The Journal of Thoracic and Cardiovascular Surgery c Augextracardiac conduit is used as a systemic venous pathway. Short-
term warfarin therapy after a Fontan operation might have prevented
the formation of intrahepatic thrombi in these cases, because both
occurred within 2 weeks after the operation.
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